OAKLAND, N.J., April 12, 2019 /PRNewswire/ -- Collagen Matrix, Inc., a leader in regenerative medicine and a global manufacturerof collagen and mineral based medical devices announced today the FDA 510(k) clearance of its innovative line of Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix through its Spine business unit.
OssiMend® Bioactive Moldable Bone
"We continue to expand our product portfolio for the Spine market with the development of this unique line of Bioactive bone graft matrices that combines a carefully-selected ratio of three powerful components. This innovative moldable version offers surgeons options for better ensuring predictable outcomes," said Bart J. Doedens, CEO of Collagen Matrix, Inc.
About Collagen MatrixCollagen Matrix, Inc., founded in 1997, delivers a full line of the highest-quality collagen and mineral based medical devices that support the body's natural ability to regenerate. The Company currently manufactures finished medical devices represented by five business units—Dental, Spine, Orthopaedic, Dural Repair and Nerve Repair. The evolution of the Company's leadership, proprietary technologies, manufacturing expertise and product portfolio has established a solid foundation for continued growth. Opportunities continue to exist for collaboration through Product Distribution, Product Development and Contract Manufacturing. More information about Collagen Matrix can be found at www.CollagenMatrix.com.
View original content:http://www.prnewswire.com/news-releases/collagen-matrix-inc-receives-fda-510k-clearance-of-a-bioactive-moldable-bone-graft-matrix-300831112.html
SOURCE Collagen Matrix, Inc.
Subscribe to our Free Newsletters!